Bingjun Sun

6.2k total citations · 2 hit papers
115 papers, 5.3k citations indexed

About

Bingjun Sun is a scholar working on Biomaterials, Biomedical Engineering and Molecular Biology. According to data from OpenAlex, Bingjun Sun has authored 115 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Biomaterials, 67 papers in Biomedical Engineering and 45 papers in Molecular Biology. Recurrent topics in Bingjun Sun's work include Nanoparticle-Based Drug Delivery (74 papers), Nanoplatforms for cancer theranostics (61 papers) and RNA Interference and Gene Delivery (21 papers). Bingjun Sun is often cited by papers focused on Nanoparticle-Based Drug Delivery (74 papers), Nanoplatforms for cancer theranostics (61 papers) and RNA Interference and Gene Delivery (21 papers). Bingjun Sun collaborates with scholars based in China, Japan and United States. Bingjun Sun's co-authors include Zhonggui He, Jin Sun, Cong Luo, Xuanbo Zhang, Shiyi Zuo, Haotian Zhang, Qiming Kan, Qin Chen, Shenwu Zhang and Yu Han and has published in prestigious journals such as Advanced Materials, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Bingjun Sun

103 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Disulfide Bond-Driven Oxidation- and Reduction-Responsive Prodrug Nanoassemblies for Cancer Therapy

2018 370 citations Bingjun Sun, Cong Luo et al. Nano Letters profile →
Emerging photodynamic nanotherapeutics for inducing immunogenic cell death and potentiating cancer immunotherapy

2022 216 citations Zhonggui He, Bingjun Sun et al. profile →

Peers

Countries citing papers authored by Bingjun Sun

Since Specialization

Citations

This map shows the geographic impact of Bingjun Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bingjun Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bingjun Sun more than expected).

Fields of papers citing papers by Bingjun Sun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bingjun Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bingjun Sun. The network helps show where Bingjun Sun may publish in the future.

Co-authorship network of co-authors of Bingjun Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Bingjun Sun. A scholar is included among the top collaborators of Bingjun Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bingjun Sun. Bingjun Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Phospholipid‐Like Prodrug Liposomes with High Drug‐carrier Affinity and High Tumor Selectivity: Strong Competitors of Paclitaxel Nanomedicines 2025 ·Advanced Functional Materials ·Danping Wang, Shanhui Xu, (unknown), (unknown), (unknown), Yixin Sun, Yaqi Li, Shiyi Zuo, Xiang Gao, Xin Li, Qikun Jiang, Zhonggui He, (unknown), (unknown), An‐Hua Wang, Bingjun Sun	0
2	Engineering stable prodrug self-assemblies by introducing the bromination effect 2025 ·Journal of Controlled Release ·Shuo Wang, (unknown), Yaqi Li, Wenjing Wang, Hao Zhang, Qing Wang, Yuhang Zhang, Xianbao Shi, Tian Liu, (unknown), Jin Sun, Bingjun Sun	2
3	Dual advantages of SN38 prodrug nanoassemblies overcome defects of irinotecan and SN38: enhanced stability and activatability 2025 ·Science China Chemistry ·Jing Xing, Cui-Yun Liu, (unknown), (unknown), Yaqi Li, Zuo‐Feng Zhang, Zhenzhen Zhao, Jin Sun, Zhonggui He, Xueyang Jiang, (unknown), Bingjun Sun	1
4	Self-assembled doxorubicin prodrug riding on the albumin express train enable tumor targeting and bio-activation 2025 ·Journal of Colloid and Interface Science ·Yanzhong Hao, Yaqiao Li, (unknown), (unknown), Xin Li, Lin Li, Zhonggui He, Bingjun Sun	6
5	GPX4 Inhibitor-Driven Doxorubicin Homodimeric Prodrug Nanoassemblies with Synergistic Chemotherapy-Ferroptosis for Triple-Negative Breast Cancer Therapy 2025 ·ACS Applied Nano Materials ·(unknown), Tiantian Lei, Kejing Wang, Yong Liu, Bingjun Sun, Lin Chen	0
6	An assembly modules deformation strategy improved the chemical stability and self-assembly stability of docetaxel prodrugs nanoassemblies 2025 ·Nanoscale ·Wenjing Wang, Shuo Wang, (unknown), Rong Chai, Jun Yuan, Hao Zhang, Yaqi Li, Xiaohui Pu, Xin Li, Jin Sun, Zhonggui He, Bingjun Sun	1
7	Emerging selenium-containing nano-systems for cancer therapy 2025 ·Coordination Chemistry Reviews ·Bowen Zhang, Xin Wang, Yi Zheng, (unknown), Qing Wang, Jin Sun, Zhonggui He, Lingxiao Li, Bingjun Sun	0
8	Effects of modification modules-adjusted intermolecular forces on docetaxel prodrug Nanoassemblies: From assembly mechanisms to in vivo fate 2025 ·Journal of Controlled Release ·Wenxiao Li, Haiyu Zhao, Jiayu Guo, Xianbao Shi, Yixin Sun, Zhonggui He, Bingjun Sun	0
9	Optimizing the stable doxorubicin prodrug nanocomplex for efficient and selective cancer therapy 2024 ·Chemical Engineering Journal ·(unknown), Jinrui Liu, (unknown), (unknown), Bowen Zhang, Shufang Zheng, Xin Li, Zhonggui He, Xin Wang, Huaiwei Ding, Lingxiao Li, Bingjun Sun	0
10	Dual role of triglyceride structures facilitates anti-tumor drug delivery: Both as a self-assembling module and a responsive module 2024 ·Journal of Colloid and Interface Science ·(unknown), Yalin Xu, Zixuan Wang, Xiyan Wang, Yaqi Li, Jinrui Liu, (unknown), Xianbao Shi, Zhonggui He, Bingjun Sun, (unknown)	2
11	Exploring the optimal chain length of modification module in disulfide bond bridged paclitaxel prodrug nanoassemblies for breast tumor treatment 2024 ·Journal of Controlled Release ·Danping Wang, (unknown), (unknown), Shuo Wang, (unknown), Yingjie Zhao, Hao Zhang, Xiyan Wang, Yuanhao Yu, Xianbao Shi, (unknown), Tian Liu, Bingjun Sun, Jin Sun	6
12	Reductants supplement boost the antitumor efficacy of nanomedicine 2024 ·Chemical Engineering Journal ·(unknown), Danping Wang, Qing Wang, (unknown), (unknown), Shiyi Zuo, Yaqiao Li, Hao‐Li Zhang, Cui-Yun Liu, Xiaohui Pu, (unknown), Yuezhou Zhang, Zhonggui He, Bingjun Sun	0
13	Revealing the impact of modified modules flexibility on gemcitabine prodrug nanoassemblies for effective cancer therapy 2024 ·Journal of Colloid and Interface Science ·Jiayu Guo, Xiaoxiao Zhang, (unknown), Simeng Wang, Danping Wang, Yaqiao Li, Shiyi Zuo, Qing Wang, Wenxiao Li, (unknown), Zhonggui He, Tianhong Zhang, Qikun Jiang, Bingjun Sun	2
14	Rational design of tumor-selective prodrug nanoassemblies: Greatly improving the in vivo fate and tolerability of high-toxic cabazitaxel 2023 ·Chemical Engineering Journal ·(unknown), Yu Zhang, (unknown), Danping Wang, Shiyi Zuo, (unknown), Zhonggui He, Qiming Kan, Xiaohong Liu, Bingjun Sun, Jin Sun	13
15	Satellite‐Type Sulfur Atom Distribution in Trithiocarbonate Bond‐Bridged Dimeric Prodrug Nanoassemblies: Achieving Both Stability and Activatability 2023 ·Advanced Materials ·Lingxiao Li, Tian Liu, Shiyi Zuo, Yaqiao Li, (unknown), Qi Lu, Danping Wang, Yixin Sun, Zhonggui He, Bingjun Sun, Jin Sun	29
16	Bioorthogonal chemistry-driven anticancer nanotherapeutics 2023 ·Trends in Chemistry ·Hongyuan Zhang, Jing Wang, Ruonan Han, Bingjun Sun, Cong Luo	12
17	Smart stimuli-responsive carrier-free nanoassembly of SN38 prodrug as efficient chemotherapeutic nanomedicine 2023 ·SHILAP Revista de lepidopterología ·Guanting Li, (unknown), (unknown), Shuwen Fu, Xuanbo Zhang, (unknown), Chutong Tian, Qingzhi Lv, Jin Sun, Zhonggui He, Bingjun Sun	20
18	Paclitaxel derivative-based liposomal nanoplatform for potentiated chemo-immunotherapy 2021 ·Journal of Controlled Release ·Yingli Wang, (unknown), Jiang Yu, Dan Li, Liwen Zhao, Bingjun Sun, Jiamei Wang, Zhenjie Wang, Shuang Zhou, Menglin Wang, Yinxian Yang, Hongzhuo Liu, Haotian Zhang, Qingzhi Lv, Qikun Jiang, Zhonggui He, (unknown), (unknown)	43
19	Redox dual-responsive paclitaxel-doxorubicin heterodimeric prodrug self-delivery nanoaggregates for more effective breast cancer synergistic combination chemotherapy 2019 ·Nanomedicine Nanotechnology Biology and Medicine ·Yingli Wang, Jiamei Wang, (unknown), Wei Wei, Bingjun Sun, (unknown), Yuxi Song, (unknown), Zhonggui He, Jin Sun, (unknown), (unknown)	29
20	Disulfide Bond-Driven Oxidation- and Reduction-Responsive Prodrug Nanoassemblies for Cancer Therapy breakdown → 2018 ·Nano Letters ·Bingjun Sun, Cong Luo, Yu Han, Xuanbo Zhang, Qin Chen, Wenqian Yang, Menglin Wang, Qiming Kan, Haotian Zhang, Yongjun Wang, Zhonggui He, Jin Sun	370

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact